CIK 0000926617 · Non-accelerated filer<br>Smaller reporting company
Aspira Women's Health Inc.
Sign in to watch- Ticker
- AWHL
- Exchange
- OTC
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330595156
- Phone
- 512-519-0400
- Business address
- 12117 BEE CAVES ROAD BUILDING THREE, SUITE 100, AUSTIN, TX, 78738
- Former names
- VERMILLION, INC., CIPHERGEN BIOSYSTEMS INC
- SC 13G Stake Amended Statement of Ownership
- DEF 14A Proxy Proxy Statement
- 8-K Event Other events
- PRE 14A Proxy Proxy Statement (Preliminary)
- UPLOAD Other SEC-generated Letter
- 424B3 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-1/A Offering Registration Statement
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1/A Offering Registration Statement
- 3/A Insider 3/A
- 10-Q Report Quarterly Report
- 3/A Insider 3/A
- 8-K Event Results of operations · Regulation FD disclosure
- 3 Insider Initial Statement of Ownership
- UPLOAD Other SEC-generated Letter
- CORRESP Other Correspondence Between Filers and SEC Staff
- 8-K Event Material agreement · Executive or director change
Page 62 of 78 · 1,549 filings